• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Bertrand Coiffier, Barbara Pro, +15 authors Steven Horwitz
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2012 (First Publication: 20 February 2012)
  • PURPOSE Romidepsin is a structurally unique, potent class 1 selective histone deacetylase inhibitor. The primary objective of this international, pivotal, single-arm, phase II trial was to confirmContinue Reading
  • Bertrand Coiffier, Barbara Pro, +14 authors Steven Horwitz
  • Medicine
  • Journal of Hematology & Oncology
  • 2014 (First Publication: 23 January 2014)
  • BackgroundRomidepsin is a structurally unique, potent, bicyclic class 1 selective histone deacetylase inhibitor approved by the US Food and Drug Administration for the treatment of patients withContinue Reading
  • Youn H Kim, Martine Bagot, +35 authors Madeleine Duvic
  • Medicine
  • The Lancet. Oncology
  • 2018 (First Publication: 1 September 2018)
  • BACKGROUND Cutaneous T-cell lymphomas are rare non-Hodgkin lymphomas with substantial morbidity and mortality in advanced disease stages. We compared the efficacy of mogamulizumab, a novel monoclonalContinue Reading
  • Sheng Cheng Wei, Xianghong Chen, +11 authors Alan F List
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences
  • 2009 (First Publication: 4 August 2009)
  • Lenalidomide is the first karyotype-selective therapeutic approved for the treatment of myelodysplastic syndromes (MDS) owing to high rates of erythroid and cytogenetic response in patients withContinue Reading